Search Results 341-350 of 15286 for CLL
-
... chronic lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and ...
-
Jacksonville, Fla. The purpose of this study is to investigate the efficacy and safety of lisaftoclax in combination with BTK inhibitors in CLL/SLL patients who ...
-
This episode of "Tomorrow's Cure" explores how a type of blood cancer, chronic lymphocytic leukemia (CLL), is hard to detect early in its development and ...
-
Chronic lymphocytic leukemia. Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with ...
-
Novel therapeutics for hematological malignancies. Treatment and outcomes of lymphoma and chronic lymphocytic leukemia. Genetics, epigenetics and immunology of ...
-
... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.
-
The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) or Small ...
-
... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.
-
Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...
-
Central nervous system involvement in patients with Richter transformation of chronic lymphocytic leukemia (CLL): the Mayo Clinic experience. Blood Cancer J ...